BTAI: BioXcel Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 23.25
Enterprise Value ($M) 69.98
Book Value ($M) -74.30
Book Value / Share -1.82
Price / Book -0.31
NCAV ($M) -75.56
NCAV / Share -1.85
Price / NCAV -0.31

Profitability (mra)
Return on Invested Capital (ROIC) -2.42
Return on Assets (ROA) -0.71
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.25
Current Ratio 2.35

Balance Sheet (mrq) ($M)
Current Assets 64.18
Assets 65.44
Liabilities 139.74
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
09-10 13G/A Fmr Llc 2.64 -57.30
06-06 13D/A Bioxcel Corp 23.50 -7.09
02-07 13G/A Adage Capital Partners Gp, L.l.c. 1.55 -69.95

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 634,647 1,739,301 36.49
2024-11-21 33,840 107,001 31.63
2024-11-20 163,024 363,827 44.81
2024-11-19 101,296 315,119 32.15
2024-11-18 147,143 353,716 41.60

(click for more detail)

Similar Companies
BNTC – Benitec Biopharma Inc. BON – Bon Natural Life Limited
BPTH – Bio-Path Holdings, Inc. BYSI – BeyondSpring Inc.
CALC – CalciMedica, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.